YRHAM
NAGE

Yong Rong (HK) Asset Management’s Niagen Bioscience NAGE Stock Holding History

Yong Rong (HK) Asset Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,933,041
Closed -$2.38M – 15
2022
Q3 		$2.38M Sell
1,933,041
-775,995
-29% -$1.25M 7.62% 5
2022
Q2 		$4.53M Sell
2,709,036
-1,365,903
-34% -$2.67M 3.53% 9
2022
Q1 		$10M Sell
4,074,939
-56,378
-1% -$154K 14.16% 5
2021
Q4 		$15.5M Hold
4,131,317
– – 12.21% 2
2021
Q3 		$25.9M Hold
4,131,317
– – 16.98% 2
2021
Q2 		$40.7M Hold
4,131,317
– – 10.13% 3
2021
Q1 		$38.6M Buy
+4,131,317
New +$32.7M 10.58% 3

Other funds holding NAGE

TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Yong Rong (HK) Asset Management's NAGE Position: Q4 2022 in Review

Yong Rong (HK) Asset Management sold out of Niagen Bioscience (NAGE) in Q4 2022, closing a stake of 1,933,041 shares — an estimated $2.38M sold.

Yong Rong (HK) Asset Management first reported a position in NAGE in Q1 2021 and held it in 7 quarters. The position peaked at $40.7M in Q2 2021. 59 funds tracked by Wall St. Rank hold NAGE as of Q4 2022.

  • Yong Rong (HK) Asset Management reported no remaining Niagen Bioscience position as of Q4 2022 after selling out during the quarter.
  • Yong Rong (HK) Asset Management sold 1,933,041 Niagen Bioscience shares in Q4 2022, an estimated $2.38M.
  • Yong Rong (HK) Asset Management first reported a position in Niagen Bioscience in Q1 2021 and held it in 7 quarters.
  • Yong Rong (HK) Asset Management's Niagen Bioscience position peaked at $40.7M in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2022.

Based on Yong Rong (HK) Asset Management's 13F filing for Q4 2022, filed 31 Jan 2023.